Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra‐articular administration to exercised Thoroughbred horses. Issue 1 (1st September 2015)
- Record Type:
- Journal Article
- Title:
- Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra‐articular administration to exercised Thoroughbred horses. Issue 1 (1st September 2015)
- Main Title:
- Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra‐articular administration to exercised Thoroughbred horses
- Authors:
- Knych, Heather K.
Harrison, Linda M.
White, Alexandria
McKemie, Daniel S. - Abstract:
- Abstract : The use of isoflupredone acetate in performance horses and the scarcity of published pharmacokinetic data necessitate further study. The objective of the current study was to describe the plasma pharmacokinetics of isoflupredone acetate as well as time‐related urine and synovial fluid concentrations following intra‐articular administration to horses. Twelve racing‐fit adult Thoroughbred horses received a single intra‐articular administration (8 mg) of isoflupredone acetate into the right antebrachiocarpal joint. Blood, urine and synovial fluid samples were collected prior to and at various times up to 28 days post drug administration. All samples were analyzed using liquid chromatography‐Mass Spectrometry. Plasma data were analyzed using a population pharmacokinetic compartmental model. Maximum measured plasma isoflupredone concentrations were 1.76 ± 0.526 ng/mL at 4.0 ± 1.31 h and 1.63 ± 0.243 ng/mL at 4.75 ± 0.5 h, respectively, for horses that had synovial fluid collected and for those that did not. The plasma beta half‐life was 24.2 h. Isoflupredone concentrations were below the limit of detection in all horses by 48 h and 7 days in plasma and urine, respectively. Isoflupredone was detected in the right antebrachiocarpal and middle carpal joints for 8.38 ± 5.21 and 2.38 ± 0.52 days, respectively. Results of this study provide information that can be used to regulate the use of intra‐articular isoflupredone in the horse. Copyright © 2015 John Wiley & Sons, Ltd.Abstract : The use of isoflupredone acetate in performance horses and the scarcity of published pharmacokinetic data necessitate further study. The objective of the current study was to describe the plasma pharmacokinetics of isoflupredone acetate as well as time‐related urine and synovial fluid concentrations following intra‐articular administration to horses. Twelve racing‐fit adult Thoroughbred horses received a single intra‐articular administration (8 mg) of isoflupredone acetate into the right antebrachiocarpal joint. Blood, urine and synovial fluid samples were collected prior to and at various times up to 28 days post drug administration. All samples were analyzed using liquid chromatography‐Mass Spectrometry. Plasma data were analyzed using a population pharmacokinetic compartmental model. Maximum measured plasma isoflupredone concentrations were 1.76 ± 0.526 ng/mL at 4.0 ± 1.31 h and 1.63 ± 0.243 ng/mL at 4.75 ± 0.5 h, respectively, for horses that had synovial fluid collected and for those that did not. The plasma beta half‐life was 24.2 h. Isoflupredone concentrations were below the limit of detection in all horses by 48 h and 7 days in plasma and urine, respectively. Isoflupredone was detected in the right antebrachiocarpal and middle carpal joints for 8.38 ± 5.21 and 2.38 ± 0.52 days, respectively. Results of this study provide information that can be used to regulate the use of intra‐articular isoflupredone in the horse. Copyright © 2015 John Wiley & Sons, Ltd. Abstract : Following intra‐articular administration to exercised Thoroughbred horses isoflupredone was detected for up to 36 and 48 h in plasma and urine, respectively. Furthermore, as isoflupredone was detected in synovial fluid for up to 14 days post administration, urine and blood concentrations do not appear to be good indicators of drug concentrations at the effector site and by and by extrapolation may not be useful in determining the duration of pharmacologic effect. … (more)
- Is Part Of:
- Drug testing and analysis. Volume 8:Issue 1(2016:Jan.)
- Journal:
- Drug testing and analysis
- Issue:
- Volume 8:Issue 1(2016:Jan.)
- Issue Display:
- Volume 8, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 8
- Issue:
- 1
- Issue Sort Value:
- 2016-0008-0001-0000
- Page Start:
- 142
- Page End:
- 148
- Publication Date:
- 2015-09-01
- Subjects:
- corticosteroid -- isoflupredone -- horse, intra‐articular -- racehorse
Drugs -- Analysis -- Periodicals
Drug testing -- Periodicals
Chemistry, Forensic -- Periodicals
615.1901 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=110501 ↗
http://www3.interscience.wiley.com/journal/121408477/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/dta.1834 ↗
- Languages:
- English
- ISSNs:
- 1942-7603
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.424000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2754.xml